Table 10 |
||||||
|
Execution time comparison, Group II |
||||||
|
Dataset |
p * c/n |
Time (min) |
Ratio |
|||
|
|
|
|||||
|
RF |
R1NN |
R3NN |
RF/R1NN |
RF/R3NN |
||
|
|
||||||
|
Lymphoma |
195 |
57 |
146 |
147 |
0.4 |
0.4 |
|
Leukemia |
161 |
18 |
74 |
74 |
0.3 |
0.2 |
|
Breast.3.Class |
154 |
310 |
332 |
334 |
0.9 |
0.9 |
|
SRBCT |
147 |
97 |
177 |
178 |
0.5 |
0.5 |
|
Shipp |
142 |
238 |
293 |
286 |
0.8 |
0.8 |
|
Breast.2.Class |
126 |
167 |
221 |
222 |
0.8 |
0.8 |
|
Prostate |
118 |
370 |
389 |
391 |
1.0 |
0.9 |
|
Khan |
111 |
745 |
452 |
451 |
1.6 |
1.7 |
|
Colon |
65 |
75 |
156 |
157 |
0.5 |
0.5 |
|
|
||||||
|
Total |
2077 |
2240 |
2240 |
0.93 |
0.93 |
|
|
|
||||||
|
Li et al. BMC Bioinformatics 2011 12:450 doi:10.1186/1471-2105-12-450 |
||||||
